## **Core Concept**
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired, life-threatening disease of the blood characterized by the destruction of red blood cells (hemolysis), bone marrow failure, and the presence of blood clots. It results from a mutation in a gene involved in the synthesis of glycosylphosphatidylinositol (GPI), which anchors proteins to the cell membrane.

## **Why the Correct Answer is Right**
The correct answer, **PIGA (Phosphatidylinositol Glycan class A)**, is the gene most commonly associated with PNH. The PIGA gene provides instructions for making one of the enzymes required for the first step in GPI anchor synthesis. Mutations in the PIGA gene lead to a deficiency of GPI anchors on the surface of blood cells, making them more susceptible to destruction by the complement system, a part of the immune system. This results in the characteristic hemolysis of PNH.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While other genes may be involved in related pathways or in the broader context of bone marrow failure syndromes, they are not primarily associated with the GPI anchor deficiency seen in PNH.
- **Option B and C:** These options are distractors and do not directly relate to the primary genetic defect causing PNH.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that PNH is often associated with **aplastic anemia** and **thrombosis**. The disease results from a somatic mutation in the PIGA gene of hematopoietic stem cells, leading to a deficiency of GPI-anchored proteins, such as CD55 and CD59, which protect cells from complement-mediated lysis.

## **Correct Answer:** . **PIGA**